Chiasma, Inc.
NASDAQ: CHMA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Raj Kannan
- Employees
- 84
- Headquarters
- Needham, United States
- IPO year
- 2015
- Website
- http://www.chiasma.com
Loading CHMA…
Loading profile data…Frequently asked questions about CHMA
What does Chiasma, Inc. (CHMA) do?
Chiasma, Inc. is a biopharmaceutical company in the advanced stages of clinical development, specializing in oral drug formulations. The company utilizes its Transient Permeability Enhancer (TPE) technology platform to develop treatments for rare and serious chronic conditions on a global scale. A key product in its pipeline is MYCAPSSA, an oral...
Where does CHMA trade?
Chiasma, Inc. (CHMA) trades on the NASDAQ Global Select.
What sector is CHMA in?
Chiasma, Inc. (CHMA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Chiasma, Inc.?
Raj Kannan is the chief executive officer of Chiasma, Inc. (CHMA).
Where is Chiasma, Inc. headquartered?
Chiasma, Inc. is headquartered in United States.
Does CHMA pay a dividend?
Chiasma, Inc. (CHMA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CHMA go public?
Chiasma, Inc. (CHMA) completed its initial public offering in 2015.